We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-4.81%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61.4M
AUM Growth
+$421K
Cap. Flow
-$3.84M
Cap. Flow %
-6.25%
Top 10 Hldgs %
36.09%
Holding
98
New
30
Increased
15
Reduced
28
Closed
20
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.3 years

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.57M
2
HCA icon
HCA Healthcare
HCA
+$2.24M
3
AAPL icon
Apple
AAPL
+$1.87M
4
ELV icon
Elevance Health
ELV
+$1.51M
5
GILD icon
Gilead Sciences
GILD
+$1.48M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$2.49M
2
AER icon
AerCap
AER
+$2.11M
3
WBA icon
Walgreens Boots Alliance
WBA
+$1.64M
4
SCHW icon
Charles Schwab
SCHW
+$1.53M
5
TXT icon
Textron
TXT
+$1.1M

Sector Composition

Rank Sector Weight
1 Healthcare 52.18%
2 Miscellaneous 15.51%
3 Technology 12.67%
4 Financials 6.92%
5 Communication Services 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HCA icon
1
HCA Healthcare
HCA
$101B
$3.31M 5.4%
42,444
+32,125
+311% +$2.24M
2013 Q2
11 quarters
ABBV icon
2
AbbVie
ABBV
$501B
$2.63M 4.28%
+46,029
New +$2.57M
2016 Q1
0 quarters
BMY icon
3
Bristol-Myers Squibb
BMY
$124B
$2.22M 3.61%
34,687
-14,235
-29% -$898K
2015 Q1
4 quarters
WBA icon
4
DELISTED
Walgreens Boots Alliance
WBA
$2.19M 3.57%
26,029
-20,529
-44% -$1.64M
2014 Q4
5 quarters
OEF icon
5
CALL
iShares S&P 100 ETF
OEF
$20.6B
$2.09M 3.4%
+8,000
New +$698K
2016 Q1
0 quarters
AAPL icon
6
Apple
AAPL
$4.99T
$2.04M 3.33%
+75,060
New +$1.87M
2016 Q1
0 quarters
BMY icon
7
CALL
Bristol-Myers Squibb
BMY
$124B
$2.02M 3.3%
31,700
+15,700
+98% +$990K
2015 Q3
2 quarters
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$13.9B
$2M 3.26%
15,336
+4,292
+39% +$534K
2015 Q1
4 quarters
AGN
9
DELISTED
Allergan plc
AGN
$1.83M 2.98%
6,822
-2,947
-30% -$844K
2015 Q3
2 quarters
EW icon
10
Edwards Lifesciences
EW
$50.8B
$1.82M 2.97%
61,962
-8,520
-12% -$235K
2014 Q4
5 quarters
ALDR
11
DELISTED
Alder Biopharmaceuticals
ALDR
$1.71M 2.78%
69,742
+32,986
+90% +$764K
2014 Q2
7 quarters
GILD icon
12
Gilead Sciences
GILD
$195B
$1.6M 2.6%
17,379
+16,446
+1,763% +$1.48M
2015 Q3
2 quarters
LRCX icon
13
Lam Research
LRCX
$347B
$1.57M 2.56%
189,980
+55,560
+41% +$404K
2015 Q4
1 quarter
ELV icon
14
Elevance Health
ELV
$92.9B
$1.57M 2.55%
+11,268
New +$1.51M
2016 Q1
0 quarters
MDCO
15
DELISTED
Medicines Co
MDCO
$1.47M 2.4%
46,338
-2,155
-4% -$70.4K
2015 Q2
3 quarters
PANW icon
16
Palo Alto Networks
PANW
$303B
$1.4M 2.29%
51,606
-30,708
-37% -$755K
2014 Q2
7 quarters
UHS icon
17
Universal Health Services
UHS
$11B
$1.4M 2.27%
11,187
-441
-4% -$49.6K
2015 Q2
3 quarters
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.27T
$1.35M 2.2%
35,340
-10,620
-23% -$391K
2015 Q4
1 quarter
AMZN icon
19
Amazon
AMZN
$2.75T
$1.31M 2.14%
44,160
-4,980
-10% -$141K
2015 Q4
1 quarter
MSFT icon
20
Microsoft
MSFT
$4.01T
$1.31M 2.13%
23,654
+15,431
+188% +$809K
2015 Q4
1 quarter
BLK icon
21
Blackrock
BLK
$174B
$1.11M 1.81%
3,272
+1,113
+52% +$353K
2015 Q4
1 quarter
ABBV icon
22
CALL
AbbVie
ABBV
$501B
$1.04M 1.69%
+18,200
New +$1.01M
2016 Q1
0 quarters
PYPL icon
23
PayPal
PYPL
$48.9B
$993K 1.62%
+25,731
New +$930K
2016 Q1
0 quarters
HRTX icon
24
Heron Therapeutics
HRTX
$71.5M
$931K 1.52%
49,049
+2,111
+4% +$41.6K
2015 Q2
3 quarters
VMC icon
25
Vulcan Materials
VMC
$32.7B
$901K 1.47%
8,530
-8,566
-50% -$812K
2014 Q1
8 quarters
1
2 3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2016 Portfolio in Review

As of Q1 2016, Partner Investment Management held 98 positions worth $61.4M, up 0.69% from $61M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Partner Investment Management withdrew a net $3.84M in Q1 2016, closing 20 positions and reducing 28 holdings. Its most notable exit was Teva Pharmaceutical Industries Limited, an estimated $2.49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 58% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Partner Investment Management opened a new position in AbbVie worth $2.63M.

  • Partner Investment Management's largest Q1 2016 buy was AbbVie: 46,029 shares worth $2.63M.
  • Partner Investment Management added most to HCA Healthcare in Q1 2016, an estimated $2.24M increase.
  • Partner Investment Management's biggest Q1 2016 reduction was Walgreens Boots Alliance, cutting an estimated $1.64M.
  • Partner Investment Management fully exited Teva Pharmaceutical Industries Limited in Q1 2016, selling an estimated $2.49M.
  • Partner Investment Management's ten largest holdings make up 36% of its $61.4M portfolio in Q1 2016.
  • Partner Investment Management opened 30 new positions and closed 20 in Q1 2016.
  • Partner Investment Management's portfolio value rose 0.69% quarter-over-quarter to $61.4M.

Based on Partner Investment Management's 13F filing for Q1 2016, filed 16 May 2016.